(S)-Sibutramine

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name(S)-Sibutramine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine receptors antagonistsAdrenergic receptors antagonists
TargetsDopamine receptorsSerotonin transporterAdrenergic receptors
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityFeeding and Eating DisordersAnxiety Disorders +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityFeeding and Eating DisordersAnxiety Disorders +[8] 

Other Information

ATC CodeN/A
Related LinksN/A